Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-1029 in Persistent Asthma
NCT01656395Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Aug 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of MK-1029 in asthma, sponsored by Merck & Co.. Started Aug 2012; status: terminated.
02
Drugs
MK-1029
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01656395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656395.